ISRCTN92984394已完成未知
A pilot study to assess flutamide monotherapy compared With maximal androgen blockade in metastatic prostate cancer
Schering-Plough Ltd (UK)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •1. Histologically confirmed prostate carcinoma
- •2. Skeletal metastases on bone scan, with radiological conformation if appropriate, or typical sclerotic metastases on X-ray
- •3. Life expectancy >6 months
- •4. Suitable for treatment by any of the study therapies
- •5. No previous hormonal therapy
- •6. Not currently receiving corticosteroids, spironolactone or aminoglutethamide
- •7. Adequate renal and hepatic function
排除标准
- •Not provided at time of registration
研究者
相似试验
进行中（未招募）
不适用
Clinical study on the efficacy of flutamide for androgen dependent dilated cardiomyopathyDilated cardiomyopathyJPRN-jRCTs051180123Onoue Kenji2
已完成
3 期
Clinical trial on the effectiveness of the Famotidine on symptoms of schizophrenic patientsSchizophreniaIRCT20190707044123N1Rasht University of Medical Sciences64
招募中
2 期
eflunomide for musculoskeletal GVHD after allogeneic stem cell transplantCTRI/2021/04/033214Dr Sachin Punatar
招募中
不适用
A pilot study to evaluate the efficacy of lafutidine in patients with paclitaxel-induced peripheral neuropathy.gynecological cancerJPRN-UMIN000011890Fukushima medical University Hospital, School of medicine30
进行中（未招募）
不适用
Multicentric Pilot Phase II Study for use of Fludarabine plus Cyclophosphamide Followed by 90 Y-Ibritumomab Tiuxetan Zevalin in the Treatment of non-Follicular Indolent Lymphomas Refractory or Relapsed after Conventional Front-Line Chemotherapy not Containing FludarabineTreatment patients with non-Follicular Indolent Lymphomas Refractory or Relapsed after Conventional Front-Line Chemotherapy not Containing Fludarabine and CiclofosfamideEUCTR2005-000699-41-ITAZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO A.O. DI RILIEVO NAZIONALE80